Astellas Pharma Inc. (TYO:4503)
2,370.00
-34.00 (-1.41%)
At close: Mar 9, 2026
Astellas Pharma Employees
Astellas Pharma had 13,643 employees as of March 31, 2025. The number of employees decreased by 1,111 or -7.53% compared to the previous year.
Employees
13,643
Change (1Y)
-1,111
Growth (1Y)
-7.53%
Revenue / Employee
151.04M JPY
Profits / Employee
23.67M JPY
Market Cap
4,306.08B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Daiichi Sankyo Company | 19,765 |
| Otsuka Holdings | 35,338 |
| Ono Pharmaceutical | 4,287 |
| Kyowa Kirin | 5,669 |
| Chugai Pharmaceutical | 7,872 |
| Santen Pharmaceutical | 3,849 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Astellas Pharma News
- 13 days ago - What's Happening With VIR Stock? - Forbes
- 13 days ago - Astellas collaborates with Vir to develop its experimental prostate cancer drug - Reuters
- 13 days ago - Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PRNewsWire
- 27 days ago - India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US - Reuters
- 2 months ago - Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines - GlobeNewsWire
- 3 months ago - Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium - PRNewsWire
- 3 months ago - Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting - PRNewsWire